Secondary Logo

Journal Logo

Editorial introductions

doi: 10.1097/01.cco.0000239876.85720.02
Editorial introductions
Free

Current Opinion in Oncology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of psychiatry is divided into 15 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.

Back to Top | Article Outline

Section Editors

Lode Swinnen

Figure 1

Figure 1

Professor Lode Swinnen gained his MB, ChB at the University of Cape Town Medical School, Cape Town, South Africa and is currently Professor of Oncology in the Division of Hematologic Malignancies at the John Hopkins School of Medicine, Baltimore.

Professor Swinnen did his fellowship in Hematology/Oncology at Loyola University Chicago and Hines VA Hospital. He is a member of the Eastern Cooperative Oncology Group and Southwest Oncology Group. Professor Swinnen has clinical interests in the lymphomas, and particularly in organ transplant and HIV associated immunodeficiency-related malignancies.

Back to Top | Article Outline

Ronald Mitsuyasu

Figure 2

Figure 2

Dr Ronald Mitsuyasu is Professor of Medicine and the Director of the UCLA Center for Clinical AIDS Research and Education (CARE Center) at the Geffen School of Medicine at the University of California, Los Angeles. Dr Mitsuyasu is an Associate Director of the UCLA AIDS Institute. He is an established clinical investigator with over 20 years of experience in HIV clinical trials research and patient care. He established one of the first clinics for Kaposi's sarcoma and AIDS malignancies at UCLA in 1983 and has directed the CARE Center since its inception in 1990. He is the current group chair of the NCI-funded AIDS Malignancy Consortium (AMC) and is director of the State of California-supported Collaborative Center for HIV/AIDS Research in California, which is known as the Network for AIDS Research in Los Angeles. He is a past chair of the Immunology Research Agenda Committee (IRAC) of the NIAID Adult AIDS Clinical Trials Group (AACTG) and has served on the Executive and Scientific Agenda Steering Committees of the AACTG.

Dr Mitsuyasu's research interests include clinical trial investigations of cytokines, immune-based therapies, biologic response modifiers, vaccines and gene therapies for HIV and treatments for AIDS-related malignancies. He has extensive background in the use of cytokines, other biologic interventions, bone marrow and stem cell transplants and other novel therapies for HIV. He has pioneered the use of gene therapy for HIV infection.

Back to Top | Article Outline

Martin Gore

Figure 3

Figure 3

Professor Martin Gore is a medical oncologist at the Royal Marsden Hospital and Institute of Cancer Research, London. His main interests are melanoma, renal cell cancer and ovarian cancer.

Professor Martin Gore qualified in medicine at St Bartholomew's Hospital, London in 1974. He trained in General Internal Medicine for 5 years and then was appointed as a Clinical Scientist at the Ludwig Institute of Cancer Research (1981–1984) where he worked on novel methods for the production of monoclonal antibodies to breast cancer using fractionated milk fat globule membrane, he was awarded a PhD for this work in 1985.

In 1984 he joined the training programme at the Royal Marsden Hospital and spent time on the Gynaecology Unit where he trained under Eve Wiltshaw. In 1988 he was appointed Consultant Cancer Physician to the Royal Marsden Hospital and Senior Lecturer at The Institute of Cancer Research and began work on the use of biological response modifiers in head and neck cancer, malignant melanoma and renal cell carcinoma. In 1993, on the retirement of Dr Eve Wiltshaw, he took over the ovarian cancer programme.

He is currently Chairman of the Department of Health's Gene Therapy Advisory Committee and Vice-Chairman of the Health and Safety Executive's Scientific Advisory Committee on Genetically Modified Organisms. In 2006 he was appointed Medical Director the Royal Marsden Hospital, London. He is on the editorial board of several journals and has published over 300 articles and edited 7 textbooks.

© 2006 Lippincott Williams & Wilkins, Inc.